Clinical Trial Update: Elimination of Minimal Residual Disease After Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining strategies to eliminate minimal residual disease after transplant in multiple myeloma; the study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING